Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-β) in normal vs cancerous breast epithelial cells

British Journal of Cancer

Volumn 86, Issue 12, 2002, Pages 1963-1969

  McCaig, C ^a   Fowler, C A ^a   Laurence, N J ^a   Lai, T ^a   Savage, P B ^a   Holly, J M P ^a   Perks, C M ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Apoptosis; Cancer; Insulin like growth factor binding protein 3 (IGFBP 3); Normal; Proliferation; TGF

Indexed keywords

CERAMIDE; COMPLEMENTARY RNA; CYTOKINE; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3; SYNTHETIC PEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER SURVIVAL; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION;

APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL DIVISION; CERAMIDES; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; RADIOIMMUNOASSAY; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRYPAN BLUE; TUMOR CELLS, CULTURED;

EID: 0037125041     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600355     Document Type: Article

References (31)

1. Tumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation
2. IGFBP-3 mediates TGF-beta1-induced cell growth in human airway smooth muscle cells
3. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3
4. The role of TGF-beta in patterning and growth of the mammary ductal tree
5. The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness
6. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor
7. Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cells
8. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner
9. The role for transforming growth factor-beta (TGF-beta) in human cancer
10. IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation
11. The role of serines in the mid region of IGFBP-3 in its autonomous actions
12. Insulin-like growth factors and their binding proteins: Biological actions
13. IGFBP-3 mediates TGF beta 1 proliferative response in colon cancer cells
14. The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor
15. Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells
16. IGF-independent effects of IGFBP-5 on breast epithelial cell survival and attachment are blocked by a synthetic RGD-containing peptide
17. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition
18. Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action
19. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells
20. Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells
21. Insulin-like growth factor binding protein-3 (IGFBP-3) modulates the phosphorylation of focal adhesion kinase (FAK) independently of IGF in Hs578T human breast cancer cells
22. Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria
23. IGFBP-3 modulates integrin signalling independently of IGF-I in Hs578T human breast cancer cells
24. Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1
25. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism
26. Transforming growth factor-beta in breast cancer: A working hypothesis
27. Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype
28. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10
29. The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics
30. Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells
31. Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production